免疫细胞代谢改变与1型糖尿病进展相关
该纵向队列研究对34例进展为1型糖尿病的儿童、27例仅血清转换出现胰岛自身抗体但未进展的儿童及10例对照进行外周血单核细胞代谢组学分析,发现生命第一年进展组和血清转换组多数脂质和极性代谢物水平低于对照组,代谢建模提示神经酰胺通路改变与1型糖尿病进展相关。
要点
- 生命第一年,进展为1型糖尿病组和血清转换组多数脂质和极性代谢物水平低于对照组。
- 代谢通路过度代表分析提示丙氨酸、天冬氨酸、谷氨酸、甘油磷脂和鞘脂代谢在进展为1型糖尿病组中过度代表。
- 代谢建模证实神经酰胺通路改变与1型糖尿病进展特异相关。
核心结论
- 数据提示,如血浆中所观察到的全身脂质代谢失调,可能在进展为显性1型糖尿病过程中影响免疫细胞的代谢和功能。
研究设计与样本
- 纵向队列研究,纳入进展为1型糖尿病儿童34例、血清转换至≥1种胰岛自身抗体但未进展为1型糖尿病儿童27例、随访期间保持自身抗体阴性对照儿童10例,进行外周血单核细胞代谢组学分析。
主要发现
- 生命第一年,进展为1型糖尿病组和血清转换组多数脂质和极性代谢物水平低于对照组。
- 通路过度代表分析提示丙氨酸、天冬氨酸、谷氨酸、甘油磷脂和鞘脂代谢在进展为1型糖尿病组中过度代表。
- 利用公开转录组学数据并以本研究代谢组学数据约束,构建了1型糖尿病进展过程中外周血单核细胞的基因组尺度代谢模型。
- 代谢建模证实神经酰胺通路改变与1型糖尿病进展特异相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Previous metabolomics studies suggest that type 1 diabetes is preceded by specific metabolic disturbances. The aim of this study was to investigate whether distinct metabolic patterns occur in peripheral blood mononuclear cells (PBMCs) of children who later develop pancreatic beta cell autoimmunity or overt type 1 diabetes. METHODS: In a longitudinal cohort setting, PBMC metabolomic analysis was applied in children who (1) progressed to type 1 diabetes (PT1D, n = 34), (2) seroconverted to ≥1 islet autoantibody without progressing to type 1 diabetes (P1Ab, n = 27) or (3) remained autoantibody negative during follow-up (CTRL, n = 10). RESULTS: During the first year of life, levels of most lipids and polar metabolites were lower in the PT1D and P1Ab groups compared with the CTRL group. Pathway over-representation analysis suggested alanine, aspartate, glutamate, glycerophospholipid and sphingolipid metabolism were over-represented in PT1D. Genome-scale metabolic models of PBMCs during type 1 diabetes progression were developed by using publicly available transcriptomics data and constrained with metabolomics data from our study. Metabolic modelling confirmed altered ceramide pathways, known to play an important role in immune regulation, as specifically associated with type 1 diabetes progression. CONCLUSIONS/INTERPRETATION: Our data suggest that systemic dysregulation of lipid metabolism, as observed in plasma, may impact the metabolism and function of immune cells during progression to overt type 1 diabetes. DATA AVAILABILITY: The GEMs for PBMCs have been submitted to BioModels (www.ebi.ac.uk/biomodels/), under accession number MODEL1905270001. The metabolomics datasets and the clinical metadata generated in this study were submitted to MetaboLights (https://www.ebi.ac.uk/metabolights/), under accession number MTBLS1015.
引用
- Sen P, Dickens AM, López-Bascón MA, et al. Metabolic alterations in immune cells associate with progression to type 1 diabetes. Diabetologia. 2020. PMID: 32043185. doi:10.1007/s00125-020-05107-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。